Leslie Patmore
Directeur/Bestuurslid bij Safety Pharmacology Society
Profiel
Leslie Patmore is currently the Managing Director at Aptuit Consulting, Inc. and the Director at Safety Pharmacology Society.
Previously, Patmore worked as the Director-Pharmacology & Toxicology at Roche Palo Alto LLC, Director-Molecular Pharmacology at Syntex Pharmaceuticals Ltd., Director-Drug Development at Antoxis Ltd., and VP-Preclinical Sciences & Pharmaceutical Analysis at IQVIA Ltd.
Patmore received an undergraduate degree in 1976 and a doctorate degree in 1979 from the University of East Anglia.
Actieve functies van Leslie Patmore
Bedrijven | Functie | Begin |
---|---|---|
Aptuit Consulting, Inc. | Corporate Officer/Principal | 09-12-2009 |
Safety Pharmacology Society | Directeur/Bestuurslid | 09-12-2009 |
Eerdere bekende functies van Leslie Patmore
Bedrijven | Functie | Einde |
---|---|---|
Syntex Pharmaceuticals Ltd. | Corporate Officer/Principal | 01-01-1995 |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
IQVIA Ltd.
IQVIA Ltd. Information Technology ServicesTechnology Services IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom. | Corporate Officer/Principal | - |
Antoxis Ltd.
Antoxis Ltd. BiotechnologyHealth Technology Antoxis Ltd. designs and develops synthesis therapeutic antioxidants. The firm also develops innovative approaches for the treatment of neurodegenerative conditions, cardiovascular disease, cancer and inflammatory disorders through its mitochondrial-targeted, redox technology platform. The company was founded by Andrew Scott Johnstone and Donald Barton Mcphail in March 2005 and is headquartered in Aberdeen, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Leslie Patmore
University of East Anglia | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
Syntex Pharmaceuticals Ltd. | |
Antoxis Ltd.
Antoxis Ltd. BiotechnologyHealth Technology Antoxis Ltd. designs and develops synthesis therapeutic antioxidants. The firm also develops innovative approaches for the treatment of neurodegenerative conditions, cardiovascular disease, cancer and inflammatory disorders through its mitochondrial-targeted, redox technology platform. The company was founded by Andrew Scott Johnstone and Donald Barton Mcphail in March 2005 and is headquartered in Aberdeen, the United Kingdom. | Health Technology |
Aptuit Consulting, Inc. | |
Safety Pharmacology Society | |
IQVIA Ltd.
IQVIA Ltd. Information Technology ServicesTechnology Services IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom. | Technology Services |